Structure Therapeutics (GPCR) Treasury Shares (2022)

Structure Therapeutics' Treasury Shares history runs 4 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 308.37% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (up 308.37% YoY), while the FY2025 annual figure was $4.3 million, up 308.37% from the prior year.
• Treasury Shares for Q4 2025 stood at $4.3 million, up from $1.1 million in the prior quarter.
• The five-year high for Treasury Shares was $32.9 million in Q2 2022, with the low at $945.0 in Q1 2024.
• The 4-year median for Treasury Shares is $1.1 million (2024), against an average of $11.3 million.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares plunged 99.57% in 2023, then soared 308.37% in 2025.
• Structure Therapeutics' Treasury Shares stood at $32.9 million in 2022, then tumbled by 99.0% to $327000.0 in 2023, then jumped by 221.41% to $1.1 million in 2024, then jumped by 308.37% to $4.3 million in 2025.
• Business Quant data shows GPCR's Treasury Shares at $4.3 million in Q4 2025, $1.1 million in Q4 2024, and $1.1 million in Q3 2024.